Location History:
- Goettingen, DE (2013)
- Bovenden, DE (2015 - 2024)
Company Filing History:
Years Active: 2013-2024
Title: Martin Dahlberg: Innovator in Biopharmaceutical Integrity Testing
Introduction
Martin Dahlberg, an accomplished inventor located in Bovenden, Germany, holds a remarkable portfolio of 10 patents. His work primarily revolves around ensuring the integrity of biopharmaceutical products, which is crucial for the safety and efficacy of medications.
Latest Patents
Among his latest innovations is a method and system that utilizes a colorimetric indicator to detect potential losses of integrity in flexible bags used for biopharmaceutical products. This invention ensures that the integrity of a filled flexible bag containing biopharmaceutical fluid is verified by a sophisticated receiving and controlling device. The device functions by placing the bag walls in contact with two parallel restraining plates while controlling test pressure. An integral part of this system is an integrity/non-integrity indicator device that features a pair of covering walls positioned between the bag and the restraining plates. Notably, a leak can be identified through a color change in a continuous colorimetric detection layer within the covering walls, whether housed in a permeable or impermeable layer.
Another significant patent focuses on an apparatus and method designed for conducting integrity tests on disposable components. This innovative device includes a medium chamber bounded externally for receiving culture medium and a sample holder that allows the sample to partially enclose the medium chamber. Furthermore, it features a vent line located on the side of the chamber away from the sample holder, enhancing its functionality.
Career Highlights
Martin's career has been enriched by his contributions to leading biopharmaceutical firms, such as Sartorius Stedim Biotech GmbH and Sartorius Stedim FMT SAS. His experience in these organizations underscores his commitment to advancing the field of biopharmaceutical integrity testing.
Collaborations
Throughout his career, Martin has collaborated with notable professionals, including Lars Boettcher and Isabelle Gay. Their combined expertise reflects a dynamic and innovative approach within the industry, further driving advancements in biopharmaceutical safety.
Conclusion
In summary, Martin Dahlberg is a visionary inventor whose contributions significantly enhance the integrity testing of biopharmaceutical products. His innovative patents and collaboration with esteemed colleagues position him as a key player in ensuring the safety and reliability of essential healthcare solutions.